Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aker BioMarine M&A Activity 2010

Nov 17, 2010

3527_rns_2010-11-17_ea2fd53f-051d-48ec-a570-f0417b0d57bd.html

M&A Activity

Open in viewer

Opens in your device viewer

AKBM - Completion of the sale of 50% of the shares in Trygg Pharma Holding AS to Lindsay Goldberg and the acquisition of EPAX Holding AS from Austevoll Seafood ASA

Reference is made to the stock exchange notice of 3 September 2010 regarding

Lindsay Goldberg's acquisition of 50 % of the shares in a newly established

joint venture company, Trygg Pharma Holding AS, from Aker BioMarine ASA, the

stock exchange notice of 3 September 2010 regarding the purchase by Trygg Pharma

AS (a wholly owned subsidiary of Trygg Pharma Holding AS) of 100% of the shares

in Epax Holding AS from Austevoll Seafood ASA, and the prospectus dated 29

September 2010 prepared in connection with the rights issue completed in Aker

BioMarine ASA.

Lindsay Goldberg's acquisition of 50% of the shares in Trygg Pharma Holding AS

from Aker BioMarine ASA and the acquisition by Trygg Pharma AS of 100% of the

shares in Epax Holding AS from Austevoll Seafood ASA have been completed in

accordance with the agreements entered into between the parties, as further

described in the abovementioned stock exchange notices and the prospectus.

This information is subject of the disclosure requirements acc. to §5-12 vphl

(Norwegian Securities Trading Act)

[HUG#1463350]